| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Saana Eskelinen, Eila Sailas, Kaisla Joutsenniemi, Matti Holi, Jaana Suvisaar. Clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. Nordic journal of psychiatry. vol 69. issue 5. 2015-12-22. PMID:25981178. |
clozapine use and sedentary lifestyle as determinants of metabolic syndrome in outpatients with schizophrenia. |
2015-12-22 |
2023-08-13 |
Not clear |
| Jean-Arthur Micoulaud-Franchi, Mitsuko Aramaki, Pierre Alexis Geoffroy, Raphaëlle Richieri, Michel Cermolacce, Catherine Faget, Sølvi Ystad, Richard Kronland-Martinet, Christophe Lancon, Jean Vion-Dur. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia. Journal of clinical psychopharmacology. vol 35. issue 2. 2015-12-21. PMID:25587694. |
effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia. |
2015-12-21 |
2023-08-13 |
Not clear |
| Jean-Arthur Micoulaud-Franchi, Mitsuko Aramaki, Pierre Alexis Geoffroy, Raphaëlle Richieri, Michel Cermolacce, Catherine Faget, Sølvi Ystad, Richard Kronland-Martinet, Christophe Lancon, Jean Vion-Dur. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia. Journal of clinical psychopharmacology. vol 35. issue 2. 2015-12-21. PMID:25587694. |
although clozapine is known to improve sensory gating assessed neurophysiologically, we hypothesized that patients with schizophrenia treated with clozapine would report less perceptual abnormalities related to sensory gating deficit than patients treated with other second-generation antipsychotics do. |
2015-12-21 |
2023-08-13 |
Not clear |
| Jean-Arthur Micoulaud-Franchi, Mitsuko Aramaki, Pierre Alexis Geoffroy, Raphaëlle Richieri, Michel Cermolacce, Catherine Faget, Sølvi Ystad, Richard Kronland-Martinet, Christophe Lancon, Jean Vion-Dur. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia. Journal of clinical psychopharmacology. vol 35. issue 2. 2015-12-21. PMID:25587694. |
forty patients with a diagnosis of schizophrenia were investigated (10 patients treated with clozapine and 30 patients treated with another second-generation antipsychotic drug). |
2015-12-21 |
2023-08-13 |
Not clear |
| Jean-Arthur Micoulaud-Franchi, Mitsuko Aramaki, Pierre Alexis Geoffroy, Raphaëlle Richieri, Michel Cermolacce, Catherine Faget, Sølvi Ystad, Richard Kronland-Martinet, Christophe Lancon, Jean Vion-Dur. Effects of clozapine on perceptual abnormalities and sensory gating: a preliminary cross-sectional study in schizophrenia. Journal of clinical psychopharmacology. vol 35. issue 2. 2015-12-21. PMID:25587694. |
although the cross-sectional design of this study is limited because causal inferences cannot be clearly concluded, the present study suggests clinical and neurophysiological advantages of clozapine compared with other second-generation antipsychotics and provides a basis for future investigations on the effect of this treatment on perceptual abnormalities related to sensory gating deficit in patients with schizophrenia. |
2015-12-21 |
2023-08-13 |
Not clear |
| Marina Mitjans, Rosa Catalán, Mireia Vázquez, Alex González-Rodríguez, Rafael Penadés, Alexandre Pons, Guillem Massana, Janet Munro, Maria J Arranz, Bárbara Aria. Hypothalamic-pituitary-adrenal system, neurotrophic factors and clozapine response: association with FKBP5 and NTRK2 genes. Pharmacogenetics and genomics. vol 25. issue 5. 2015-12-21. PMID:25751398. |
in this study, we investigated the role of genes related to the hypothalamic-pituitary-adrenal axis (fkbp5 and nr3c1) and neurotrophic factors (bdnf and ntrk2) in clinical response to clozapine in 591 schizophrenia patients. |
2015-12-21 |
2023-08-13 |
Not clear |
| Francesco Franza, Vincenzo Fasano, Serena De Guglielmo, Barbara Solomit. Management of primary negative symptoms in schizophrenia: an one-year observational study. Psychiatria Danubina. vol 27 Suppl 1. 2015-12-17. PMID:26417773. |
in our study, we evaluated in an open-label study the efficacy of some second-generation antipsychotics (clozapine, quetiapine, olanzapine, aripiprazole, paliperidone) in 42 patients with schizophrenia or schizoaffective disorder (dsm-5 criteria) with 'persistent negative symptoms'. |
2015-12-17 |
2023-08-13 |
Not clear |
| Anna Emilia Urban, Mariusz S Wiglusz, Wiesław Jerzy Cubała, Jerzy Landowski, Krzysztof Kryst. Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine. Psychiatria Danubina. vol 27 Suppl 1. 2015-12-17. PMID:26417816. |
clozapine is the treatment of choice in drug-resistant schizophrenia. |
2015-12-17 |
2023-08-13 |
Not clear |
| Jan P A M Bogers, Hong Bui, Martien Herruer, Dan Cohe. Capillary compared to venous blood sampling in clozapine treatment: patients׳ and healthcare practitioners׳ experiences with a point-of-care device. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 3. 2015-12-15. PMID:25548103. |
underuse of the antipsychotic clozapine for schizophrenia is an impediment to improving outcomes for patients. |
2015-12-15 |
2023-08-13 |
Not clear |
| Jagadeesh V V Settem, Satyakant Trivedi, Avinash G Kamath, Rishikesh V Behere, Haridas Kanaradi, Sripathy M Bha. Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil. Indian journal of psychological medicine. vol 37. issue 3. 2015-12-15. PMID:26664091. |
clozapine is known to be an effective antipsychotic for schizophrenia. |
2015-12-15 |
2023-08-13 |
Not clear |
| Jagadeesh V V Settem, Satyakant Trivedi, Avinash G Kamath, Rishikesh V Behere, Haridas Kanaradi, Sripathy M Bha. Clozapine-induced Supraventricular Tachycardia and its Treatment with Verapamil. Indian journal of psychological medicine. vol 37. issue 3. 2015-12-15. PMID:26664091. |
we report a case of a 45-year-old man with treatment resistant schizophrenia who developed supraventricular tachycardia during initiation of clozapine and discuss the role of verapamil in its successful management. |
2015-12-15 |
2023-08-13 |
Not clear |
| Gabrielle Crépeau-Gendron, Sophie L'Heureu. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report. Early intervention in psychiatry. vol 9. issue 2. 2015-12-07. PMID:24690066. |
quetiapine xr-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? |
2015-12-07 |
2023-08-12 |
Not clear |
| Z Whitney, R M Procyshyn, D H Fredrikson, A M Bar. Treatment of clozapine-associated weight gain: a systematic review. European journal of clinical pharmacology. vol 71. issue 4. 2015-11-30. PMID:25627831. |
clozapine is an antipsychotic drug with superior efficacy in treatment-resistant schizophrenia. |
2015-11-30 |
2023-08-13 |
Not clear |
| François R Girardin, Antoine Poncet, Marc Blondon, Victoria Rollason, Nathalie Vernaz, Yves Chalandon, Pierre Dayer, Christophe Combescur. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. The lancet. Psychiatry. vol 1. issue 1. 2015-11-26. PMID:26360402. |
monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. |
2015-11-26 |
2023-08-13 |
Not clear |
| François R Girardin, Antoine Poncet, Marc Blondon, Victoria Rollason, Nathalie Vernaz, Yves Chalandon, Pierre Dayer, Christophe Combescur. Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis. The lancet. Psychiatry. vol 1. issue 1. 2015-11-26. PMID:26360402. |
we aimed to assess the cost-effectiveness of various strategies to monitor white blood cell count in adult patients with schizophrenia taking clozapine. |
2015-11-26 |
2023-08-13 |
Not clear |
| Andrew M Williams, Susie H Par. Seizure associated with clozapine: incidence, etiology, and management. CNS drugs. vol 29. issue 2. 2015-11-17. PMID:25537107. |
given clozapine's strong evidence for efficacy in the treatment of schizophrenia and schizoaffective disorder, every attempt to manage side effects, including seizure, should be implemented to allow for therapeutic continuation. |
2015-11-17 |
2023-08-13 |
Not clear |
| Mei-Ling Hou, Chi-Hung Lin, Lie-Chwen Lin, Tung-Hu Tsa. The Drug-Drug Effects of Rhein on the Pharmacokinetics and Pharmacodynamics of Clozapine in Rat Brain Extracellular Fluid by In Vivo Microdialysis. The Journal of pharmacology and experimental therapeutics. vol 355. issue 1. 2015-11-17. PMID:26220937. |
clozapine, an atypical antipsychotic agent, is highly effective in treatment-resistant schizophrenia; however, its major side effect is constipation. |
2015-11-17 |
2023-08-13 |
rat |
| S A J de With, S L Pulit, T Wang, W G Staal, W W van Solinge, P I W de Bakker, R A Ophof. Genome-wide association study of lymphoblast cell viability after clozapine exposure. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 168B. issue 2. 2015-11-16. PMID:25656473. |
clozapine is an antipsychotic drug with proven efficacy in treatment-resistant schizophrenia but also known to induce potentially lethal agranulocytosis (cia) in 1% of patients. |
2015-11-16 |
2023-08-13 |
Not clear |
| Heather Gage, Hannah Family, Fenella Murphy, Peter Williams, Jane Sutton, Denise Taylo. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of advanced nursing. vol 71. issue 3. 2015-11-10. PMID:25376164. |
comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. |
2015-11-10 |
2023-08-13 |
Not clear |
| Heather Gage, Hannah Family, Fenella Murphy, Peter Williams, Jane Sutton, Denise Taylo. Comparison of sole nurse and team-delivered community clozapine services for people with treatment-resistant schizophrenia. Journal of advanced nursing. vol 71. issue 3. 2015-11-10. PMID:25376164. |
to compare sole nurse and doctor-led multidisciplinary team delivery of community clozapine services for people with treatment-resistant schizophrenia. |
2015-11-10 |
2023-08-13 |
Not clear |